Traian Sulea

This inventor holds 34 USPTO granted patents and 11 published patent applications, plus 25 CIPO patents and 16 EPO patents, primarily in Antibody Engineering. Top assignees: National Research Council of Canada, Alethia Biotherapeutics Inc., Adc Therapeutics Sa. Active years: 2012-2026.

USPTO Granted Patents = 34 (Patent Applications = 11)

% Patents Active = 88.2

CIPO Patents = 25 (Patent Applications = 23)

EPO Patents = 16 (Patent Applications = 32)

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 83(Granted Patents)

Location History:

Ottawa, CA (2021)
Kirkland, CA (2012 - 2024)

Company Filing History:

24 out of 1,039

National Research Council of Canada

patents

5 out of 19

Alethia Biotherapeutics Inc.

Gilead Sciences, Inc.

patents

5. 2 out of 1,959

University of Pittsburgh

9. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Antibody Variants

TGF-Beta Inhibitors

EGFR Antibodies

Pain Management

Tumor Targeting

Blood-Brain Barrier

Humanized Antibodies

Fusion Proteins

G-CSF Antibodies

Kidney Antigens

Selective Targeting

Antagonists

34 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12576133 - ANTIGEN-BINDING AGENTS THAT SPECIFICALLY BIND EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III (2026-03-17),

2. 12540186 - ANTI-EGFRVIII ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THEREOF (2026-02-03),

3. 12428460 - Engineered TGF-beta monomers and their use for inhibiting TGF-beta signaling (2025-09-30),

4. 12421308 - Anti-G-CSF antibodies and uses thereof (2025-09-23),

5. 12392777 - Antibody variants with pH-dependent antigen binding for selective targeting of solid tumors (2025-08-19),

6. 12391743 - TGF-β-receptor ectodomain fusion molecules and uses thereof (2025-08-19),

7. 12084510 - Antibodies selective for cells presenting EGFR at high density (2024-09-10),

8. 11945858 - Antibodies and antibody fragments against HNAV1.7 channel and their use in pain and cancer indications (2024-04-02),

9. 11866481 - TGF-β-receptor ectodomain fusion molecules and uses thereof (2024-01-09),

10. 11591408 - Antibody glycoconjugates and methods of production and use (2023-02-28),

11. 11384141 - Serum albumin binding antibodies for tuneable half-life extension of biologics (2022-07-12),

12. 11359010 - Humanized anti-S100A9 antibody and uses thereof (2022-06-14),

13. 11091523 - Engineered TGF-β monomers and their use for inhibiting TGF-β signaling (2021-08-17),

14. 10906973 - Antibody variants transmigrating the blood-brain barrier and uses thereof (2021-02-02),

15. 10738115 - Humanized antibodies transmigrating the blood-brain barrier and uses thereof (2020-08-11),

Title: The Innovative Mind of Traian Sulea

Introduction: Traian Sulea, a brilliant inventor hailing from Kirkland, CA, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Traian Sulea's recent patents include cutting-edge advancements in artificial intelligence algorithms for autonomous vehicles, smart home technology, and renewable energy solutions.

Career Highlights: With a career spanning over two decades, Traian Sulea has worked with top tech companies in Silicon Valley, leading research teams and spearheading projects that have revolutionized various industries.

Collaborations: Throughout his career, Traian Sulea has collaborated with renowned scientists, engineers, and researchers from prestigious universities and research institutions worldwide, fostering a culture of innovation and excellence.

Conclusion: Traian Sulea's passion for pushing the boundaries of technology and his relentless pursuit of innovation continue to inspire the next generation of inventors and visionaries in the ever-evolving landscape of technological advancement.